|
1
|
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system.
|
J Clin Oncol
|
2001
|
10.20
|
|
2
|
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma.
|
J Clin Oncol
|
2001
|
9.68
|
|
3
|
A novel AKT3 mutation in melanoma tumours and cell lines.
|
Br J Cancer
|
2008
|
2.63
|
|
4
|
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy.
|
Ann Surg Oncol
|
2001
|
2.19
|
|
5
|
Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis.
|
Am J Pathol
|
1997
|
2.15
|
|
6
|
Sentinel lymph node biopsy for melanoma: how many radioactive nodes should be removed?
|
Ann Surg Oncol
|
2001
|
1.66
|
|
7
|
Significance of multiple nodal basin drainage in truncal melanoma patients undergoing sentinel lymph node biopsy.
|
Ann Surg Oncol
|
2000
|
1.57
|
|
8
|
A new American Joint Committee on Cancer staging system for cutaneous melanoma.
|
Cancer
|
2000
|
1.52
|
|
9
|
Phase II trial of imatinib mesylate in patients with metastatic melanoma.
|
Br J Cancer
|
2008
|
1.43
|
|
10
|
Loss of AP-2 results in up-regulation of MCAM/MUC18 and an increase in tumor growth and metastasis of human melanoma cells.
|
J Biol Chem
|
1998
|
1.33
|
|
11
|
Patterns of regional and distant metastasis in patients with conjunctival melanoma: experience at a cancer center over four decades.
|
Ophthalmology
|
2001
|
1.25
|
|
12
|
Sentinel lymph node biopsy for melanoma: controversy despite widespread agreement.
|
J Clin Oncol
|
2001
|
1.10
|
|
13
|
Tolerance to endotoxin prevents mortality in infected thermal injury: association with attenuated cytokine responses.
|
J Infect Dis
|
1992
|
1.02
|
|
14
|
Significance of plasma cytokine levels in melanoma patients with histologically negative sentinel lymph nodes.
|
Ann Surg Oncol
|
2001
|
1.01
|
|
15
|
Surgical margins and prognostic factors in patients with thick (>4mm) primary melanoma.
|
Ann Surg Oncol
|
1998
|
0.98
|
|
16
|
Multimethod imaging, staging, and spectrum of manifestations of metastatic melanoma.
|
Clin Radiol
|
2011
|
0.93
|
|
17
|
Sentinel lymph node biopsy for conjunctival melanoma.
|
Ophthal Plast Reconstr Surg
|
2001
|
0.90
|
|
18
|
Epidermal hyperplasia overlying human melanoma correlates with tumour depth and angiogenesis.
|
Melanoma Res
|
2003
|
0.82
|
|
19
|
How many lymph nodes are enough during sentinel lymphadenectomy for primary melanoma?
|
Surgery
|
2000
|
0.79
|
|
20
|
Clinical relevance of melanoma micrometastases in sentinel nodes: too early to tell.
|
Ann Oncol
|
2007
|
0.77
|
|
21
|
Monoclonal antibodies to avian lipoprotein lipase. Purification of the enzyme by immunoaffinity chromatography.
|
Biochim Biophys Acta
|
1985
|
0.75
|
|
22
|
Retracted
[Effects of vascular endothelial growth factor D on the signaling cascade of sentinel lymphatic endothelial cells from melanoma patients undergoing sentinel lymphadenectomy].
|
Gan To Kagaku Ryoho
|
2003
|
0.75
|